Equal coronavirus vaccine access a “real issue”

Though several pharma companies are rushing to produce a vaccine for the coronavirus causing the COVID-19 pandemic, aided by expedited regulatory processes, questions still remain over how count

Pharma companies that don’t change during COVID-19 will be ‘...

Janssen’s former clinical innovation VP Andreas Koester has warned that pharma companies that go back to how they were working before the COVID-19 crisis could soon find themselves irrelevant on

FDA approves AZ Imfinzi in new lung cancer use

AstraZeneca has reported a double win after the FDA approved its Imfinzi for a form of lung cancer, and it stopped a trial of its Farxiga after showing “overwhelming efficacy” in chronic ki

FDA grants emergency use of malaria drugs against COVID-19

The FDA has approved emergency use of malaria drugs championed by president Donald Trump for use in patients hospitalised with COVID-19, after warning against the potentially lethal consequ

Sanofi inks COVID-19 mRNA vaccine deal with Translate Bio

Sanofi’s Pasteur vaccines unit has joined with the US biotech Translate Bio to announce a partnership to develop an mRNA vaccine against the coronavirus that causes the COVID-19 pandemic.

Takeda signs $882m rare disease alliance with Oxford biotech...